Help Print this page 

Document 31996R0282

Title and reference
Commission Regulation (EC) No 282/96 of 14 February 1996 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
  • No longer in force, Date of end of validity: 05/07/2009; Implicitly repealed by 32009R0470
OJ L 37, 15.2.1996, p. 12–14 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
Special edition in Czech: Chapter 03 Volume 018 P. 443 - 445
Special edition in Estonian: Chapter 03 Volume 018 P. 443 - 445
Special edition in Latvian: Chapter 03 Volume 018 P. 443 - 445
Special edition in Lithuanian: Chapter 03 Volume 018 P. 443 - 445
Special edition in Hungarian Chapter 03 Volume 018 P. 443 - 445
Special edition in Maltese: Chapter 03 Volume 018 P. 443 - 445
Special edition in Polish: Chapter 03 Volume 018 P. 443 - 445
Special edition in Slovak: Chapter 03 Volume 018 P. 443 - 445
Special edition in Slovene: Chapter 03 Volume 018 P. 443 - 445
Special edition in Bulgarian: Chapter 03 Volume 018 P. 153 - 155
Special edition in Romanian: Chapter 03 Volume 018 P. 153 - 155

ELI: http://data.europa.eu/eli/reg/1996/282/oj
Multilingual display
Authentic language
  • Authentic language: Spanish, Danish, German, Greek, English, French, Italian, Dutch, Portuguese, Finnish, Swedish, Icelandic, Norwegian
Dates
  • Date of document: 14/02/1996
  • Date of effect: 15/04/1996; Entry into force Date pub. + 60 See Art 2
  • Date of end of validity: 05/07/2009; Implicitly repealed by 32009R0470
Miscellaneous information
  • Author: European Commission
  • Form: Regulation
  • Additional information: Extended to the EEA by 21997D0904(12) EEA relevance
Relationship between documents
Text

15.2.1996   

EN

Official Journal of the European Communities

L 37/12


COMMISSION REGULATION (EC) No 282/96

of 14 February 1996

amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 281/96 (2), and in particular Articles 6, 7 and 8 thereof,

Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals;

Whereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs;

Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue);

Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney; whereas, however, the liver and kidney are frequently removed from carcases moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues;

Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey;

Whereas cefquinome should be inserted into Annex I to Regulation (EEC) No 2377/90;

Whereas buserelin, ketoprofen, caffeine, theophylline and theobromine should be inserted into Annex II to Regulation (EEC) No 2377/90;

Whereas, in order to allow for the completion of scientific studies, josamycin, decoquinate and colistin should be inserted into Annex III to Regulation (EEC) No 2377/90;

Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorizations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851/EEC (3), as last amended by Directive 93/40/EEC (4), to take account of the provisions of this Regulation;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes I, II and III to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

Article 2

This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 14 February 1996.

For the Commission

Martin BANGEMANN

Member of the Commission


(1)  OJ No L 224, 18. 8. 1990, p. 1.

(2)  See page 9 of this Official Journal.

(3)  OJ No L 317, 6. 11. 1981, p. 1.

(4)  OJ No L 214, 24. 8. 1993, p. 31.


ANNEX

A.

Annex I is amended as follows:

1.

Anti-infectious agents

1.2.

Antibiotics

1.2.2.

Cephalosporins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘1.2.2.1.

Cefquinome

Cefquinome

Bovine

20 μg/kg

Milk’

 

B.

Annex II (2. ‘Organic compounds’) is amended as follows:

2.

Organic chemicals

Pharmacologically active substance(s)

Animal species

Other provisions

‘2.29.

Buserelin

All food producing species

 

2.30.

Ketoprofen

Bovine, equidae

 

2.31.

Caffeine

All food producing species

 

2.32.

Theophylline

All food producing species

 

2.33.

Theobromine

All food producing species’

 

C.

Annex III is amended as follows:

1.

Anti-infectious agents

1.2.

Antibiotics

1.2.2

Macrolides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘1.2.2.4.

Josamycin

Josamycin

Chicken

400 μg/kg

Kidney

Provisional MRLs expire on 1 July 2000’

200 μg/kg

Liver, muscle, fat

200 μg/kg

Eggs

1.2.6.

Quinolones

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘1.2.6.2.

Decoquinate

Decoquinate

Bovine, ovine

500 μg/kg

Muscle, liver, kidney, fat

Provisional MRLs expire on 1 July 2000’

1.2.8.

Polymyxins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘1.2.8.1.

Colistin

Colistin

Bovine, ovine, porcine, chicken, rabbits

200 μg/kg

Kidney

Provisional MRLs expire on 1 July 2000’

150 μg/kg

Liver, muscle, fat

Bovine, ovine

50 μg/kg

Milk

Chicken

300 μg/kg

Eggs


Top